Although the underlying cause can be osteolytic metastases, hypercalcemia of malignancy is usually caused by secretion of an active peptide such as parathyroid hormone-related peptide (PTHrP), parathyroid hormone (PTH) or calcitriol [4, 5]. Here, PTHLH is linked to hypercalcemia disease.